Scott Hutton Biodesix Inc (BDSX) insider trading activity

Scott Hutton is President & CEO of BIODESIX INC. Currently has a direct ownership of 532,979 shares of BDSX, which is worth approximately $772,819. The most recent transaction as insider was on Nov 12, 2024, when has been sold 1,813 shares (Common Stock) at a price of $1.4 per share, resulting in proceeds of $2,538. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 533K

2.82% 3M change

61.79% 12M change

Total Value Held $772,819

Scott Hutton Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 12 2024	SELL Open market or private sale	$2,538 $1.4 p/Share	1,813 Reduced 0.34%	532,979 Common Stock
Nov 11 2024	SELL Open market or private sale	$2,678 $1.39 p/Share	1,927 Reduced 0.36%	534,792 Common Stock
Nov 08 2024	BUY Exercise of conversion of derivative security	-	12,212 Added 2.22%	536,719 Common Stock
Aug 12 2024	SELL Open market or private sale	$1,511 $1.57 p/Share	963 Reduced 0.19%	518,368 Common Stock
Aug 09 2024	SELL Open market or private sale	$4,449 $1.6 p/Share	2,781 Reduced 0.53%	519,331 Common Stock
Aug 08 2024	BUY Exercise of conversion of derivative security	-	12,212 Added 2.29%	522,112 Common Stock
May 23 2024	BUY Exercise of conversion of derivative security	-	26,120 Added 4.87%	509,900 Common Stock
May 09 2024	SELL Open market or private sale	$5,570 $1.48 p/Share	3,764 Reduced 0.77%	483,780 Common Stock
May 08 2024	BUY Exercise of conversion of derivative security	-	12,212 Added 2.44%	487,544 Common Stock
Feb 12 2024	SELL Open market or private sale	$49,315 $1.66 p/Share	29,708 Reduced 6.01%	465,011 Common Stock
Feb 09 2024	SELL Open market or private sale	$66,589 $1.92 p/Share	34,682 Reduced 6.55%	494,719 Common Stock
Feb 08 2024	BUY Exercise of conversion of derivative security	-	199,973 Added 27.42%	529,401 Common Stock
Nov 10 2023	SELL Open market or private sale	$2,316 $1.23 p/Share	1,883 Reduced 0.57%	329,428 Common Stock
Nov 09 2023	SELL Open market or private sale	$2,390 $1.27 p/Share	1,882 Reduced 0.56%	331,311 Common Stock
Nov 08 2023	BUY Exercise of conversion of derivative security	-	12,212 Added 3.54%	333,193 Common Stock
Aug 10 2023	SELL Open market or private sale	$8,749 $1.27 p/Share	6,889 Reduced 2.12%	318,013 Common Stock
Aug 09 2023	SELL Open market or private sale	$9,581 $1.39 p/Share	6,893 Reduced 2.08%	324,902 Common Stock
Aug 08 2023	BUY Exercise of conversion of derivative security	-	44,777 Added 11.89%	331,795 Common Stock
Aug 03 2023	BUY Grant, award, or other acquisition	$74,999 $1.62 p/Share	46,296 Added 13.89%	287,018 Common Stock
May 10 2023	SELL Open market or private sale	$6,079 $1.58 p/Share	3,848 Reduced 1.57%	240,722 Common Stock
May 09 2023	SELL Open market or private sale	$15,596 $1.57 p/Share	9,934 Reduced 3.9%	244,570 Common Stock
May 08 2023	BUY Exercise of conversion of derivative security	-	44,778 Added 14.96%	254,504 Common Stock
Feb 09 2023	SELL Open market or private sale	$29,300 $1.8 p/Share	16,278 Reduced 7.54%	199,726 Common Stock
Feb 08 2023	BUY Exercise of conversion of derivative security	-	44,777 Added 17.17%	216,004 Common Stock
Nov 21 2022	BUY Grant, award, or other acquisition	$74,999 $1.15 p/Share	65,217 Added 27.58%	171,227 Common Stock

Scott Hutton

President & CEO

Boulder, CO

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BDSX shares.

Notify only if

Value

Insider Trading

Get notified when an Biodesix Inc insider buys or sells BDSX shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIODESIX INC

Track Activities on BDSX

Account